Emergent BioSolutions Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EBS New York 2830 www.emergentbiosolutions.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Emergent BioSolutions Inc.

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply - Jun 23rd, 2025 6:05 am
Emergent BioSolutions Announces Addition to Russell 3000® Index - Jun 20th, 2025 6:13 am
Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies - Jun 5th, 2025 5:00 am
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost - May 29th, 2025 7:55 am
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions - May 19th, 2025 7:43 am
5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes - May 16th, 2025 8:52 am
Emergent BioSolutions to Participate in Upcoming Investor Conferences - May 14th, 2025 5:32 am
Emergent BioSolutions Inc (EBS) Q1 2025 Earnings Call Highlights: Strong Net Income Growth Amid ... - May 8th, 2025 1:33 am
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - May 7th, 2025 3:35 pm
Emergent Biosolutions: Q1 Earnings Snapshot - May 7th, 2025 2:32 pm
Emergent BioSolutions Reports First Quarter 2025 Financial Results - May 7th, 2025 2:05 pm
Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health - May 1st, 2025 3:07 pm
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025 - Apr 22nd, 2025 6:00 am
Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last? - Apr 10th, 2025 7:52 am
Emergent BioSolutions Announces Stock Repurchase Program - Mar 31st, 2025 6:00 am
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08 - Mar 20th, 2025 2:30 pm
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg - Mar 20th, 2025 6:06 am
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International - Mar 19th, 2025 2:30 pm
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products - Mar 18th, 2025 6:00 am
High Growth Tech Stocks In The US Market March 2025 - Mar 13th, 2025 11:08 am